The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron. New York Times By BY KATHERINE J. WU AND KATIE THOMAS from NYT Health https://ift.tt/31lgGsv October 13, 2020 at 09:56AM
No comments:
Post a Comment